TUESDAY, Jan. 10 (HealthDay News) — A drug commonly used to treat patients with Alzheimer’s disease does not appear to be effective for people older than 40 years who have Down syndrome and Alzheimer’s, according to a new study.
Read this article:
... continue reading
Researchers have discovered that the genetic mechanism which destroys brain cells is responsible for early development of Alzheimer’s disease in people with Down syndrome and for development of Alzheimer’s disease in general population — providing a potential new target for drugs that could forestall dementia in people with either condition.
Read ... continue reading
Neuroscientists have demonstrated an association among Alzheimer’s disease, Down syndrome and atherosclerosis. Their research implicates damage inflicted by the amyloid protein as a shared disease mechanism.
Read more:
Studies demonstrate link among Alzheimer’s disease, Down syndrome ... continue reading